| Literature DB >> 31845436 |
Abstract
Keywords: Drug safety; Health Canada; OxyContin; Purdue Pharma; opioids; pharmaceutical industry; physicians; postmarketing; prescribing promotion
Mesh:
Substances:
Year: 2020 PMID: 31845436 DOI: 10.1111/add.14929
Source DB: PubMed Journal: Addiction ISSN: 0965-2140 Impact factor: 6.526